323 related articles for article (PubMed ID: 25577565)
21. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
Tonelli AR; Alnuaimat H; Mubarak K
Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
[TBL] [Abstract][Full Text] [Related]
22. Survival in schistosomiasis-associated pulmonary arterial hypertension.
dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
[TBL] [Abstract][Full Text] [Related]
23. Right-heart function related to the results of acute pulmonary vasodilator testing in patients with pulmonary arterial hypertension caused by connective tissue disease.
Liu YT; Li MT; Fang Q; Tian Z; Guo XX; Zhu WL; Wang Q; Zeng XF
J Am Soc Echocardiogr; 2012 Mar; 25(3):274-9. PubMed ID: 22137255
[TBL] [Abstract][Full Text] [Related]
24. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
Kylhammar D; Persson L; Hesselstrand R; Rådegran G
Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
[TBL] [Abstract][Full Text] [Related]
25. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
[TBL] [Abstract][Full Text] [Related]
26. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of acute vasoresponsiveness in patients with pulmonary hypertension: treatment implications.
Arunthari V; Heckman MG; Burger CD
South Med J; 2010 Jul; 103(7):630-4. PubMed ID: 20531064
[TBL] [Abstract][Full Text] [Related]
28. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
[TBL] [Abstract][Full Text] [Related]
31. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
32. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
33. Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.
Langleben D; Orfanos S
Pulm Circ; 2017; 7(3):588-597. PubMed ID: 28632001
[TBL] [Abstract][Full Text] [Related]
34. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost.
Wolff B; Lodziewski S; Bollmann T; Opitz CF; Ewert R
Am Heart J; 2007 Jun; 153(6):1088.e1-7. PubMed ID: 17540215
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.
Newman JH; Brittain EL; Robbins IM; Hemnes AR
Chest; 2015 Apr; 147(4):1080-1085. PubMed ID: 25340330
[TBL] [Abstract][Full Text] [Related]
36. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension.
Montani D; Savale L; Natali D; Jaïs X; Herve P; Garcia G; Humbert M; Simonneau G; Sitbon O
Eur Heart J; 2010 Aug; 31(15):1898-907. PubMed ID: 20543192
[TBL] [Abstract][Full Text] [Related]
37. Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.
Leuchte HH; Baezner C; Baumgartner RA; Muehling O; Neurohr C; Behr J
Heart; 2015 Jun; 101(12):972-6. PubMed ID: 26015441
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study.
Jardim C; Rochitte CE; Humbert M; Rubenfeld G; Jasinowodolinski D; Carvalho CR; Souza R
Eur Respir J; 2007 Mar; 29(3):476-81. PubMed ID: 17135232
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
[TBL] [Abstract][Full Text] [Related]
40. Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study.
Naranjo M; Rosenzweig EB; Hemnes AR; Jacob M; Desai A; Hill NS; Larive AB; Finet JE; Leopold J; Horn E; Frantz R; Rischard F; Erzurum S; Beck G; Mathai SC; Hassoun PM;
Pulm Circ; 2023 Jul; 13(3):e12281. PubMed ID: 37614830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
